HIV-1_pr-L90M

ANTIVIRAL RESISTANT STRAIN


EVAg

Produced by
: UNIBAS
Shipping From
: Basel - CH

Product Description

Ref-SKU:
006V-03426
L90M mutation in the protease gene, which can confer drug resistance to specific HIV-1 PR inhibitors. The respective mutations have been reported in viruses from HIV-infected individuals on PR inhibitors with virologic therapy failure.
Product Risk Group: 

Storage conditions: 
Viral Storage Medium -80C
Sequencing: 
Complete genome
Infectivity: 
Infectivity tested and quantified
Mycoplasmic content: 
Mycoplasma free

Unit definition: 
10e8 RNA copies

In stock

2 000,00 €
(Cost per access for Academics)

catalogue

biobank

Portal

EVAg

purchase

buy

order

price

cost

shipping

shipment

experiment

research

laboratory

viral

virus

Special feature: 
GMO: 
No
Biosafety restrictions: 
strictly handle within BSL-3 facility
Virus host type: 
Infectivity Test: 
infection of a suitable human CD4-positive leukocyte cell linet
Viral titer: 
10e7/mL
Production cell line: 
Virus Cultivability: 
Shipping conditions: 
IATA Classification: 

Information about the collection of the virus

Recombinant product: 
This product is a recombinant product
Biological material origin: 
Synthetic origin & Natural origin